Skip to main content
Caplight Logo









CURO Biosciences Private Limited

CURO Biosciences Private Limited

Private
NagpurHealthcare & Life Scienceshttps://erlysign.com/

Last Round

Early Funding

Jan 16, 2025

Total Funding Raised

$2.02M

Company Overview

CURO Biosciences Private Limited is a biotechnology company that develops non-invasive, saliva-based diagnostic test kits for the early detection of oral cancer and other conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

cancer detectionsaliva-based diagnosticsCRISPR diagnosticsliquid biopsyoral cancer screeningnon-invasive testingbiomarker assayearly cancer screeningmolecular diagnosticsdiagnostic test kitat-home health testprecision medicinemedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CURO Biosciences Private Limited Comparables

Compare CURO Biosciences Private Limited with similar companies based on industry and business-model similarity.

CURO Biosciences Private Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vigilant Biosciences
83%
InnoTech Precision Medicine
80%
OrisDX
78%

CURO Biosciences Private Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 16, 2025
SeedOct 1, 2021

Key People

Founding team and executive leadership

Deovrat Begde

Chief Scientific Officer and Co-founder

Founding Team

CURO Biosciences Private Limited Investors

Notable investors and investment history

CURO Biosciences Private Limited investors
InvestorRounds
IAN GroupSeed
LetsVenture OnlineSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2026

    Monthly visitors grew 319% MoM, reaching 2.6K.

  • Feb 23, 2026

    Grew 40% QoQ, from 10 to 14 employees.

CURO Biosciences Private Limited Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CURO Biosciences Private Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CURO Biosciences Private Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersNagpur
Employee Range14
Year Founded2019
Last FundingJan 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?